Shanghai Henlius Biotech, a Chinese drug developer controlled by Fosun Group, has filed for a Hong Kong IPO. Third-party investors include Loyal Valley Capital and China International Capital Corporation (CICC).
The company was established in 2010 as a wholly-owned subsidiary of Fosun Pharma, which remains the controlling shareholder with around 61%. There have been multiple rounds of pre-IPO investments in the...
Legend Capital sees Mancando's extensive network of brick-and-mortar outlets as the key to bringing greater supply chain efficiency to the Chinese auto parts industry
Advantage Partners has made its first acquisition in Vietnam, buying women’s fashion brand Elise Fashion for an undisclosed amount.
GIC Private has led a RMB850 million ($125.5 million) Series C round for Burning Rock, a Chinese cancer diagnostics start-up that is already working with hospitals on products based on DNA sequencing analysis.
Beacon Venture Capital, the VC unit of Thailand’s Kasikornbank, has led a $6.5 million investment in Jitta, a local financial technology provider and stock analysis platform operator.